GO:0009135 | purine nucleoside diphosphate metabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0046031 | ADP metabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0019364 | pyridine nucleotide catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009134 | nucleoside diphosphate catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009137 | purine nucleoside diphosphate catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009154 | purine ribonucleotide catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009261 | ribonucleotide catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0046032 | ADP catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0006096 | glycolytic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0006195 | purine nucleotide catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0072526 | pyridine-containing compound catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0072523 | purine-containing compound catabolic process | 9.43% (5/53) | 6.1 | 0.0 | 0.0 |
GO:0009132 | nucleoside diphosphate metabolic process | 9.43% (5/53) | 6.08 | 0.0 | 0.0 |
GO:0009166 | nucleotide catabolic process | 9.43% (5/53) | 6.05 | 0.0 | 0.0 |
GO:1901292 | nucleoside phosphate catabolic process | 9.43% (5/53) | 5.98 | 0.0 | 0.0 |
GO:0046434 | organophosphate catabolic process | 9.43% (5/53) | 5.87 | 0.0 | 0.0 |
GO:0006090 | pyruvate metabolic process | 9.43% (5/53) | 5.71 | 0.0 | 1e-06 |
GO:0046496 | nicotinamide nucleotide metabolic process | 9.43% (5/53) | 5.6 | 0.0 | 1e-06 |
GO:0019362 | pyridine nucleotide metabolic process | 9.43% (5/53) | 5.58 | 0.0 | 1e-06 |
GO:1901136 | carbohydrate derivative catabolic process | 9.43% (5/53) | 5.53 | 0.0 | 1e-06 |
GO:0016052 | carbohydrate catabolic process | 9.43% (5/53) | 5.52 | 0.0 | 1e-06 |
GO:0072524 | pyridine-containing compound metabolic process | 9.43% (5/53) | 5.39 | 0.0 | 2e-06 |
GO:0030955 | potassium ion binding | 5.66% (3/53) | 7.9 | 0.0 | 3e-06 |
GO:0004743 | pyruvate kinase activity | 5.66% (3/53) | 7.9 | 0.0 | 3e-06 |
GO:0031420 | alkali metal ion binding | 5.66% (3/53) | 7.9 | 0.0 | 3e-06 |
GO:0034655 | nucleobase-containing compound catabolic process | 9.43% (5/53) | 5.22 | 0.0 | 3e-06 |
GO:0046034 | ATP metabolic process | 9.43% (5/53) | 5.18 | 0.0 | 4e-06 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 9.43% (5/53) | 5.11 | 0.0 | 4e-06 |
GO:0044270 | cellular nitrogen compound catabolic process | 9.43% (5/53) | 5.11 | 0.0 | 4e-06 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 9.43% (5/53) | 5.11 | 0.0 | 4e-06 |
GO:0046700 | heterocycle catabolic process | 9.43% (5/53) | 5.11 | 0.0 | 4e-06 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 9.43% (5/53) | 5.04 | 0.0 | 5e-06 |
GO:0009141 | nucleoside triphosphate metabolic process | 9.43% (5/53) | 4.99 | 1e-06 | 6e-06 |
GO:0019439 | aromatic compound catabolic process | 9.43% (5/53) | 4.77 | 1e-06 | 1.2e-05 |
GO:1901361 | organic cyclic compound catabolic process | 9.43% (5/53) | 4.76 | 1e-06 | 1.2e-05 |
GO:1901565 | organonitrogen compound catabolic process | 9.43% (5/53) | 4.68 | 2e-06 | 1.5e-05 |
GO:0009150 | purine ribonucleotide metabolic process | 9.43% (5/53) | 4.64 | 2e-06 | 1.7e-05 |
GO:0009259 | ribonucleotide metabolic process | 9.43% (5/53) | 4.57 | 2e-06 | 2.2e-05 |
GO:0019693 | ribose phosphate metabolic process | 9.43% (5/53) | 4.54 | 3e-06 | 2.3e-05 |
GO:0006091 | generation of precursor metabolites and energy | 9.43% (5/53) | 4.45 | 3e-06 | 3e-05 |
GO:0019752 | carboxylic acid metabolic process | 13.21% (7/53) | 3.43 | 4e-06 | 3.2e-05 |
GO:0006082 | organic acid metabolic process | 13.21% (7/53) | 3.42 | 4e-06 | 3.3e-05 |
GO:0043436 | oxoacid metabolic process | 13.21% (7/53) | 3.42 | 4e-06 | 3.3e-05 |
GO:0032787 | monocarboxylic acid metabolic process | 9.43% (5/53) | 4.42 | 4e-06 | 3.3e-05 |
GO:0006163 | purine nucleotide metabolic process | 9.43% (5/53) | 4.38 | 4e-06 | 3.5e-05 |
GO:0072521 | purine-containing compound metabolic process | 9.43% (5/53) | 4.29 | 6e-06 | 4.7e-05 |
GO:0009117 | nucleotide metabolic process | 9.43% (5/53) | 4.18 | 9e-06 | 6.6e-05 |
GO:0006753 | nucleoside phosphate metabolic process | 9.43% (5/53) | 4.16 | 9e-06 | 6.9e-05 |
GO:0044281 | small molecule metabolic process | 15.09% (8/53) | 2.93 | 9e-06 | 7e-05 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 9.43% (5/53) | 3.9 | 2.2e-05 | 0.000159 |
GO:1901135 | carbohydrate derivative metabolic process | 9.43% (5/53) | 3.8 | 3e-05 | 0.000216 |
GO:0044248 | cellular catabolic process | 9.43% (5/53) | 3.55 | 6.9e-05 | 0.000482 |
GO:0019637 | organophosphate metabolic process | 9.43% (5/53) | 3.3 | 0.000153 | 0.001048 |
GO:0003674 | molecular_function | 67.92% (36/53) | 0.67 | 0.000187 | 0.001263 |
GO:0005975 | carbohydrate metabolic process | 11.32% (6/53) | 2.78 | 0.000233 | 0.001541 |
GO:0043169 | cation binding | 18.87% (10/53) | 1.92 | 0.000253 | 0.001649 |
GO:0008150 | biological_process | 50.94% (27/53) | 0.82 | 0.000587 | 0.003701 |
GO:0000287 | magnesium ion binding | 5.66% (3/53) | 4.2 | 0.000598 | 0.003714 |
GO:1901564 | organonitrogen compound metabolic process | 26.42% (14/53) | 1.39 | 0.000609 | 0.00372 |
GO:0016740 | transferase activity | 24.53% (13/53) | 1.47 | 0.000586 | 0.003755 |
GO:1901575 | organic substance catabolic process | 9.43% (5/53) | 2.83 | 0.000676 | 0.004067 |
GO:0009056 | catabolic process | 9.43% (5/53) | 2.78 | 0.000798 | 0.004726 |
GO:0046872 | metal ion binding | 16.98% (9/53) | 1.82 | 0.0009 | 0.00525 |
GO:0003824 | catalytic activity | 41.51% (22/53) | 0.92 | 0.001124 | 0.006463 |
GO:0005795 | Golgi stack | 1.89% (1/53) | 9.64 | 0.001256 | 0.007017 |
GO:0008455 | alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity | 1.89% (1/53) | 9.64 | 0.001256 | 0.007017 |
GO:0006807 | nitrogen compound metabolic process | 28.3% (15/53) | 1.16 | 0.001811 | 0.009972 |
GO:0009987 | cellular process | 33.96% (18/53) | 1.01 | 0.001857 | 0.010084 |
GO:0032272 | negative regulation of protein polymerization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0043242 | negative regulation of protein-containing complex disassembly | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0031984 | organelle subcompartment | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0051016 | barbed-end actin filament capping | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0051494 | negative regulation of cytoskeleton organization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0051693 | actin filament capping | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:1901879 | regulation of protein depolymerization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0031333 | negative regulation of protein-containing complex assembly | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0030837 | negative regulation of actin filament polymerization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0030835 | negative regulation of actin filament depolymerization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0061929 | gamma-glutamylaminecyclotransferase activity | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0008835 | diaminohydroxyphosphoribosylaminopyrimidine deaminase activity | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0098791 | Golgi apparatus subcompartment | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0030834 | regulation of actin filament depolymerization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0004046 | aminoacylase activity | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0008290 | F-actin capping protein complex | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:1901880 | negative regulation of protein depolymerization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:1902904 | negative regulation of supramolecular fiber organization | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain | 1.89% (1/53) | 8.64 | 0.002511 | 0.010672 |
GO:0046483 | heterocycle metabolic process | 13.21% (7/53) | 1.89 | 0.002683 | 0.011282 |
GO:0008152 | metabolic process | 33.96% (18/53) | 0.99 | 0.002192 | 0.01174 |
GO:0071704 | organic substance metabolic process | 32.08% (17/53) | 1.0 | 0.002878 | 0.011973 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 3.77% (2/53) | 4.64 | 0.00297 | 0.012223 |
GO:1901360 | organic cyclic compound metabolic process | 13.21% (7/53) | 1.82 | 0.003462 | 0.014101 |
GO:0005488 | binding | 45.28% (24/53) | 0.73 | 0.003599 | 0.014509 |
GO:0045048 | protein insertion into ER membrane | 1.89% (1/53) | 8.05 | 0.003764 | 0.014718 |
GO:0004807 | triose-phosphate isomerase activity | 1.89% (1/53) | 8.05 | 0.003764 | 0.014718 |
GO:0051205 | protein insertion into membrane | 1.89% (1/53) | 8.05 | 0.003764 | 0.014718 |
GO:0051017 | actin filament bundle assembly | 1.89% (1/53) | 7.64 | 0.005016 | 0.01904 |
GO:0061572 | actin filament bundle organization | 1.89% (1/53) | 7.64 | 0.005016 | 0.01904 |
GO:0016151 | nickel cation binding | 1.89% (1/53) | 7.64 | 0.005016 | 0.01904 |
GO:0035999 | tetrahydrofolate interconversion | 1.89% (1/53) | 7.31 | 0.006266 | 0.022897 |
GO:0004372 | glycine hydroxymethyltransferase activity | 1.89% (1/53) | 7.31 | 0.006266 | 0.022897 |
GO:0019264 | glycine biosynthetic process from serine | 1.89% (1/53) | 7.31 | 0.006266 | 0.022897 |
GO:0006545 | glycine biosynthetic process | 1.89% (1/53) | 7.31 | 0.006266 | 0.022897 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 1.89% (1/53) | 7.05 | 0.007514 | 0.025773 |
GO:0030291 | protein serine/threonine kinase inhibitor activity | 1.89% (1/53) | 7.05 | 0.007514 | 0.025773 |
GO:1904030 | negative regulation of cyclin-dependent protein kinase activity | 1.89% (1/53) | 7.05 | 0.007514 | 0.025773 |
GO:0004860 | protein kinase inhibitor activity | 1.89% (1/53) | 7.05 | 0.007514 | 0.025773 |
GO:0007031 | peroxisome organization | 1.89% (1/53) | 7.05 | 0.007514 | 0.025773 |
GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity | 1.89% (1/53) | 7.05 | 0.007514 | 0.025773 |
GO:0006486 | protein glycosylation | 3.77% (2/53) | 3.91 | 0.007927 | 0.026719 |
GO:0043413 | macromolecule glycosylation | 3.77% (2/53) | 3.91 | 0.007927 | 0.026719 |
GO:0016757 | glycosyltransferase activity | 7.55% (4/53) | 2.37 | 0.007406 | 0.026814 |
GO:0070085 | glycosylation | 3.77% (2/53) | 3.86 | 0.008512 | 0.028446 |
GO:0006730 | one-carbon metabolic process | 1.89% (1/53) | 6.83 | 0.008761 | 0.028787 |
GO:0043244 | regulation of protein-containing complex disassembly | 1.89% (1/53) | 6.83 | 0.008761 | 0.028787 |
GO:0044238 | primary metabolic process | 28.3% (15/53) | 0.93 | 0.008879 | 0.028931 |
GO:0046653 | tetrahydrofolate metabolic process | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0033673 | negative regulation of kinase activity | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0008375 | acetylglucosaminyltransferase activity | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0006469 | negative regulation of protein kinase activity | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0070569 | uridylyltransferase activity | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0001933 | negative regulation of protein phosphorylation | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0042326 | negative regulation of phosphorylation | 1.89% (1/53) | 6.64 | 0.010007 | 0.030331 |
GO:0042727 | flavin-containing compound biosynthetic process | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0042726 | flavin-containing compound metabolic process | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0019239 | deaminase activity | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0006771 | riboflavin metabolic process | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0110053 | regulation of actin filament organization | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0051129 | negative regulation of cellular component organization | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0030832 | regulation of actin filament length | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0010639 | negative regulation of organelle organization | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0032970 | regulation of actin filament-based process | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0030833 | regulation of actin filament polymerization | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0016842 | amidine-lyase activity | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0009231 | riboflavin biosynthetic process | 1.89% (1/53) | 6.47 | 0.011251 | 0.030762 |
GO:0051348 | negative regulation of transferase activity | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0033500 | carbohydrate homeostasis | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0042593 | glucose homeostasis | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:1902903 | regulation of supramolecular fiber organization | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0032271 | regulation of protein polymerization | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0043254 | regulation of protein-containing complex assembly | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0005536 | glucose binding | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0004396 | hexokinase activity | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0001678 | intracellular glucose homeostasis | 1.89% (1/53) | 6.31 | 0.012493 | 0.032137 |
GO:0006793 | phosphorus metabolic process | 13.21% (7/53) | 1.46 | 0.012836 | 0.032172 |
GO:0043167 | ion binding | 24.53% (13/53) | 0.96 | 0.012783 | 0.032247 |
GO:0006796 | phosphate-containing compound metabolic process | 13.21% (7/53) | 1.47 | 0.012643 | 0.032311 |
GO:0006725 | cellular aromatic compound metabolic process | 11.32% (6/53) | 1.63 | 0.012747 | 0.032364 |
GO:0006544 | glycine metabolic process | 1.89% (1/53) | 6.18 | 0.013734 | 0.033354 |
GO:0090066 | regulation of anatomical structure size | 1.89% (1/53) | 6.18 | 0.013734 | 0.033354 |
GO:0010563 | negative regulation of phosphorus metabolic process | 1.89% (1/53) | 6.18 | 0.013734 | 0.033354 |
GO:0045936 | negative regulation of phosphate metabolic process | 1.89% (1/53) | 6.18 | 0.013734 | 0.033354 |
GO:0032535 | regulation of cellular component size | 1.89% (1/53) | 6.18 | 0.013734 | 0.033354 |
GO:0031400 | negative regulation of protein modification process | 1.89% (1/53) | 5.94 | 0.016211 | 0.03865 |
GO:0140103 | catalytic activity, acting on a glycoprotein | 1.89% (1/53) | 5.94 | 0.016211 | 0.03865 |
GO:0019210 | kinase inhibitor activity | 1.89% (1/53) | 5.94 | 0.016211 | 0.03865 |
GO:0044092 | negative regulation of molecular function | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0043086 | negative regulation of catalytic activity | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0070006 | metalloaminopeptidase activity | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0019932 | second-messenger-mediated signaling | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0019722 | calcium-mediated signaling | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 1.89% (1/53) | 5.83 | 0.017447 | 0.039894 |
GO:0004707 | MAP kinase activity | 1.89% (1/53) | 5.73 | 0.018682 | 0.042469 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 1.89% (1/53) | 5.64 | 0.019915 | 0.044752 |
GO:0006760 | folic acid-containing compound metabolic process | 1.89% (1/53) | 5.64 | 0.019915 | 0.044752 |
GO:0004177 | aminopeptidase activity | 1.89% (1/53) | 5.55 | 0.021147 | 0.04698 |
GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses | 1.89% (1/53) | 5.55 | 0.021147 | 0.04698 |
GO:0048523 | negative regulation of cellular process | 3.77% (2/53) | 3.14 | 0.021858 | 0.048285 |
GO:0008235 | metalloexopeptidase activity | 1.89% (1/53) | 5.47 | 0.022377 | 0.048608 |
GO:0042558 | pteridine-containing compound metabolic process | 1.89% (1/53) | 5.47 | 0.022377 | 0.048608 |
GO:0046914 | transition metal ion binding | 9.43% (5/53) | 1.63 | 0.02221 | 0.048788 |